HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased high affinity 3H-imipramine binding in platelets of enuretic children and adolescents.

Abstract
High affinity 3H-imipramine binding sites have been demonstrated in human brain and platelet membranes. It has been suggested that these binding sites selectively label serotonin transporter or uptake sites. Since imipramine has a beneficial effect in the treatment of nocturnal enuresis, the present study was carried out to investigate a possible association between alteration in 3H-imipramine binding parameters in enuretics in comparison to nonenuretic control subjects. 3H-Imipramine binding to platelets was examined in 16 enuretic children and adolescents and compared to that in 22 healthy subjects of similar ages. A significant reduction was observed in the number of 3H-imipramine binding sites, while the dissociation constants (Kd) did not differ significantly in the platelets of enuretics as compared to controls. 3H-Imipramine binding values did not discriminate between familial and nonfamilial enuresis. These results may indicate that an alteration in the serotonin transporter in peripheral or central neuronal levels might be involved in the pathophysiology of nocturnal enuresis.
AuthorsA Weizman, C Carel, S Tyano, M Rehavi
JournalPsychiatry research (Psychiatry Res) Vol. 14 Issue 1 Pg. 39-46 (Jan 1985) ISSN: 0165-1781 [Print] Ireland
PMID3857647 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Tritium
  • Imipramine
Topics
  • Adolescent
  • Blood Platelets (metabolism)
  • Child
  • Enuresis (genetics, metabolism)
  • Female
  • Humans
  • Imipramine (metabolism)
  • Male
  • Tritium

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: